Literature DB >> 30193847

CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.

Luxi Chen1, Youssef Youssef2, Cameron Robinson3, Gabrielle F Ernst3, Mary Y Carson3, Karen A Young2, Steven D Scoville1, Xiaoli Zhang4, Regine Harris3, Palak Sekhri3, Anthony G Mansour3, Wing K Chan5, Ansel P Nalin1, Hsiaoyin C Mao3, Tiffany Hughes3, Emily M Mace6, Yinghong Pan7, Navin Rustagi7, Sujash S Chatterjee7, Preethi H Gunaratne7, Gregory K Behbehani5, Bethany L Mundy-Bosse5, Michael A Caligiuri8, Aharon G Freud9.   

Abstract

According to the established model of murine innate lymphoid cell (ILC) development, helper ILCs develop separately from natural killer (NK) cells. However, it is unclear how helper ILCs and NK cells develop in humans. Here we elucidated key steps of NK cell, ILC2, and ILC3 development within human tonsils using ex vivo molecular and functional profiling and lineage differentiation assays. We demonstrated that while tonsillar NK cells, ILC2s, and ILC3s originated from a common CD34-CD117+ ILC precursor pool, final steps of ILC2 development deviated independently and became mutually exclusive from those of NK cells and ILC3s, whose developmental pathways overlapped. Moreover, we identified a CD34-CD117+ ILC precursor population that expressed CD56 and gave rise to NK cells and ILC3s but not to ILC2s. These data support a model of human ILC development distinct from the mouse, whereby human NK cells and ILC3s share a common developmental pathway separate from ILC2s.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human innate lymphoid cells; ILC development; natural killer cells

Mesh:

Substances:

Year:  2018        PMID: 30193847      PMCID: PMC6148384          DOI: 10.1016/j.immuni.2018.08.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

1.  Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

Authors:  Kazuyo Moro; Hiroki Kabata; Masanobu Tanabe; Satoshi Koga; Natsuki Takeno; Miho Mochizuki; Koichi Fukunaga; Koichiro Asano; Tomoko Betsuyaku; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2015-11-23       Impact factor: 25.606

Review 2.  Transcriptional regulation of innate lymphoid cell fate.

Authors:  Nicolas Serafini; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

Review 3.  Development of innate lymphoid cells.

Authors:  Erin C Zook; Barbara L Kee
Journal:  Nat Immunol       Date:  2016-06-21       Impact factor: 25.606

4.  Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.

Authors:  Elisa Montaldo; Luiz Gustavo Teixeira-Alves; Timor Glatzer; Pawel Durek; Ulrik Stervbo; Wiebke Hamann; Marina Babic; Daniela Paclik; Katharina Stölzel; Jörn Gröne; Laura Lozza; Kerstin Juelke; Nadine Matzmohr; Fabrizio Loiacono; Francesca Petronelli; Nicholas David Huntington; Lorenzo Moretta; Maria Cristina Mingari; Chiara Romagnani
Journal:  Immunity       Date:  2014-11-28       Impact factor: 31.745

5.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

6.  IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Authors:  Naoko Satoh-Takayama; Sarah Lesjean-Pottier; Paulo Vieira; Shinichiro Sawa; Gerard Eberl; Christian A J Vosshenrich; James P Di Santo
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

7.  A committed precursor to innate lymphoid cells.

Authors:  Michael G Constantinides; Benjamin D McDonald; Philip A Verhoef; Albert Bendelac
Journal:  Nature       Date:  2014-02-09       Impact factor: 49.962

8.  IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.

Authors:  Yuefeng Huang; Liying Guo; Jin Qiu; Xi Chen; Jane Hu-Li; Ulrich Siebenlist; Peter R Williamson; Joseph F Urban; William E Paul
Journal:  Nat Immunol       Date:  2014-12-22       Impact factor: 25.606

9.  Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells.

Authors:  Steven D Scoville; Aharon G Freud; Michael A Caligiuri
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

10.  The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor.

Authors:  Corey R Seehus; Parinaz Aliahmad; Brian de la Torre; Iliyan D Iliev; Lindsay Spurka; Vincent A Funari; Jonathan Kaye
Journal:  Nat Immunol       Date:  2015-04-27       Impact factor: 25.606

View more
  44 in total

1.  CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

Authors:  Bérengère Salomé; Alejandra Gomez-Cadena; Romain Loyon; Madeleine Suffiotti; Valentina Salvestrini; Tania Wyss; Giulia Vanoni; Dan Fu Ruan; Marianna Rossi; Alessandra Tozzo; Paolo Tentorio; Elena Bruni; Carsten Riether; Eva-Maria Jacobsen; Peter Jandus; Curdin Conrad; Manfred Hoenig; Ansgar Schulz; Katarzyna Michaud; Matteo Giovanni Della Porta; Silvia Salvatore; Ping-Chih Ho; David Gfeller; Adrian Ochsenbein; Domenico Mavilio; Antonio Curti; Emanuela Marcenaro; Alexander Steinle; Amir Horowitz; Pedro Romero; Sara Trabanelli; Camilla Jandus
Journal:  Blood Adv       Date:  2019-11-26

Review 2.  Cellular pathways in the development of human and murine innate lymphoid cells.

Authors:  Steven D Scoville; Aharon G Freud; Michael A Caligiuri
Journal:  Curr Opin Immunol       Date:  2018-12-19       Impact factor: 7.486

3.  Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis.

Authors:  Madison R Mack; Jonathan R Brestoff; Melissa M Berrien-Elliott; Anna M Trier; Ting-Lin B Yang; Matthew McCullen; Patrick L Collins; Haixia Niu; Nancy D Bodet; Julia A Wagner; Eugene Park; Amy Z Xu; Fang Wang; Rebecca Chibnall; M Laurin Council; Carrie Heffington; Friederike Kreisel; David J Margolis; David Sheinbein; Paola Lovato; Eric Vivier; Marina Cella; Marco Colonna; Wayne M Yokoyama; Eugene M Oltz; Todd A Fehniger; Brian S Kim
Journal:  Sci Transl Med       Date:  2020-02-26       Impact factor: 17.956

Review 4.  Plasticity of innate lymphoid cell subsets.

Authors:  Suzanne M Bal; Korneliusz Golebski; Hergen Spits
Journal:  Nat Rev Immunol       Date:  2020-02-27       Impact factor: 53.106

5.  Discovery of specialized NK cell populations infiltrating human melanoma metastases.

Authors:  Lucas Ferrari de Andrade; Yuheng Lu; Adrienne Luoma; Yoshinaga Ito; Deng Pan; Jason W Pyrdol; Charles H Yoon; Guo-Cheng Yuan; Kai W Wucherpfennig
Journal:  JCI Insight       Date:  2019-12-05

6.  Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.

Authors:  Dejene M Tufa; Ashley M Yingst; George Devon Trahan; Tyler Shank; Dallas Jones; Seonhui Shim; Jessica Lake; Kevin Winkler; Laura Cobb; Renee Woods; Kenneth Jones; Michael R Verneris
Journal:  Sci Immunol       Date:  2020-11-20

7.  Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development.

Authors:  Ansel P Nalin; Jesse J Kowalski; Alexander C Sprague; Blaire K Schumacher; Adam G Gerhardt; Youssef Youssef; Kiran V Vedantam; Xiaoli Zhang; Christian W Siebel; Emily M Mace; Michael A Caligiuri; Bethany L Mundy-Bosse; Aharon G Freud
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

Review 8.  True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity.

Authors:  Luke Riggan; Aharon G Freud; Timothy E O'Sullivan
Journal:  Trends Immunol       Date:  2019-09-06       Impact factor: 16.687

9.  Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming.

Authors:  Hongji Zhang; Tianmeng Chen; Jinghua Ren; Yujia Xia; Amblessed Onuma; Yu Wang; Jiayi He; Junru Wu; Han Wang; Ahmad Hamad; Chengli Shen; Jinxiang Zhang; John M Asara; Gregory K Behbehani; Haitao Wen; Meihong Deng; Allan Tsung; Hai Huang
Journal:  Nat Metab       Date:  2021-06-14

10.  High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.

Authors:  Anne-Sophie Chretien; Raynier Devillier; Samuel Granjeaud; Charlotte Cordier; Clemence Demerle; Nassim Salem; Julia Wlosik; Florence Orlanducci; Laurent Gorvel; Stephane Fattori; Marie-Anne Hospital; Jihane Pakradouni; Emilie Gregori; Magali Paul; Philippe Rochigneux; Thomas Pagliardini; Mathieu Morey; Cyril Fauriat; Nicolas Dulphy; Antoine Toubert; Herve Luche; Marie Malissen; Didier Blaise; Jacques A Nunès; Norbert Vey; Daniel Olive
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.